SCHEMBL9842771

SCHEMBL9842771

Cn1c(=O)c2c(ncn2CC2(C)OCCO2)n(C2CC2)c1=O

nearest known ligand 0.50

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.50
ADORA2B P29275 12/20 0.41
LMNA P02545 2/20 0.41
MAPT P10636 1/20 0.41
PDE4A P27815 2/20 0.41
ADORA2A P29274 2/20 0.41
PDE4B Q07343 2/20 0.41
PDE4C Q08493 2/20 0.41
PDE4D Q08499 2/20 0.41
RXFP1 Q9HBX9 2/20 0.40
MAPK1 P28482 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9842841 0.85 PDE4A (0.49) KMT2AADORA2BLMNAMAPTPDE4A
SCHEMBL9842686 0.80 ADORA2B (0.43) ADORA2BLMNAPDE4AADORA2APDE4B
SCHEMBL9842681 0.79 PDE4A (0.62) KMT2AADORA2BLMNAPDE4AADORA2A
SCHEMBL9842692 0.78 PDE4A (0.63) KMT2AADORA2BLMNAMAPTPDE4A
SCHEMBL9842831 0.76 RXFP1 (0.67) KMT2AADORA2BLMNAMAPTPDE4A
SCHEMBL9842660 0.75 RXFP1 (0.72) KMT2AADORA2BLMNAMAPTPDE4A
SCHEMBL27387998 0.74 SMN1; SMN2 (0.71) ADORA2BLMNARXFP1MAPK1SMN1; SMN2
SCHEMBL11057370 0.74 PDE4A (0.48) KMT2AADORA2BPDE4AADORA2APDE4B
SCHEMBL11058131 0.74 PDE4A (0.62) ADORA2BLMNAMAPTPDE4AADORA2A
SCHEMBL9842640 0.72 AKR1B1 (0.48) ADORA2BLMNAPDE4AADORA2APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0430025-A2 Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same HOKURIKU PHARMACEUTICAL CO., LTD. (JP) 1991-06-05 EP disclosed